$ANTH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anthera Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anthera Pharmaceuticals Inc. Get notifications about new insider transactions in Anthera Pharmaceuticals Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.65 | 1,847,074 | 3,047,672 | 1,847,074 | |
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | SHANAHAN WILLIAM R JR | Chief Medical Offic ... | Option Exercise | A | 1.65 | 567,876 | 936,995 | 567,876 | |
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | A | 1.65 | 427,066 | 704,659 | 427,066 | |
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Furse Brent | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | Furse Brent | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Jan 09 2018 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 1.65 | 84,705 | 139,763 | 84,705 | ||
Sep 20 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Buy | P | 1.32 | 8,550 | 11,286 | 19,848 | 11.3 K to 19.8 K (+75.68 %) |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 28.16 | 10,000 | 281,600 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 22.88 | 926 | 21,187 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 75.94 | 3,750 | 284,775 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 75.84 | 5,000 | 379,200 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 12.88 | 15,000 | 193,200 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 26.40 | 843 | 22,255 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 24.16 | 10,000 | 241,600 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 39.04 | 10,938 | 427,020 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 96.64 | 9 | 870 | 0 | |
Sep 15 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | J | 96.64 | 365 | 35,274 | 0 | |
Sep 07 2017 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Buy | P | 1.34 | 5,000 | 6,700 | 16,793 | 11.8 K to 16.8 K (+42.40 %) | |
Sep 07 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Buy | M | 1.43 | 10,400 | 14,893 | 17,590 | 7.2 K to 17.6 K (+144.65 %) |
May 22 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.63 | 81,250 | 132,438 | 81,250 | |
May 22 2017 | ANTH | Anthera Pharmaceut ... | Olson Charles V | Chief Technology Of ... | Option Exercise | A | 1.63 | 43,750 | 71,313 | 43,750 | |
May 22 2017 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 1.63 | 43,750 | 71,313 | 43,750 | |
May 22 2017 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | A | 1.63 | 53,125 | 86,594 | 53,125 | |
May 22 2017 | ANTH | Anthera Pharmaceut ... | SHANAHAN WILLIAM R JR | Chief Medical Offic ... | Option Exercise | A | 1.63 | 75,000 | 122,250 | 75,000 | |
May 19 2017 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chaiman | Option Exercise | J | 39.04 | 84,376 | 3,294,039 | 0 | |
May 19 2017 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chaiman | Option Exercise | J | 96.64 | 1,369 | 132,300 | 0 | |
Mar 03 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Dec 08 2016 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 2.00 | 83,910 | 167,820 | 83,910 | ||
Dec 08 2016 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 2.00 | 83,910 | 167,820 | 83,910 | ||
Dec 06 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chairman | Option Exercise | J | 9.48 | 180,000 | 1,706,400 | 0 | |
Dec 06 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Executive Chairman | Option Exercise | J | 9.48 | 170,000 | 1,611,600 | 0 | |
Dec 06 2016 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.47 | 300,000 | 441,000 | 300,000 | |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Option Exercise | M | 2.08 | 5,008 | 10,417 | 25,845 | |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Gift | G | 0.00 | 5,008 | 0 | 94,345 | 89.3 K to 94.3 K (+5.61 %) |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Gift | G | 0.00 | 5,008 | 0 | 0 | 5 K to 0 (-100.00 %) |
Sep 22 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Buy | M | 2.08 | 5,008 | 10,417 | 5,008 | 0 to 5 K |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 3.52 | 105,000 | 369,600 | 105,000 | |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & COO | Option Exercise | A | 3.52 | 170,000 | 598,400 | 170,000 | |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | LIU MAY | Principal Accountin ... | Option Exercise | A | 3.52 | 80,000 | 281,600 | 80,000 | |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | Olson Charles V | CHIEF TECHNOLOGY OF ... | Option Exercise | A | 3.52 | 100,000 | 352,000 | 100,000 | |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Option Exercise | A | 3.52 | 300,000 | 1,056,000 | 300,000 | |
Apr 29 2016 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 3.80 | 62,069 | 235,862 | 62,069 | ||
Apr 29 2016 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 3.80 | 41,379 | 157,240 | 41,379 | ||
Apr 29 2016 | ANTH | Anthera Pharmaceut ... | ENGLE STEVEN B | Option Exercise | A | 3.80 | 41,379 | 157,240 | 41,379 | ||
Apr 29 2016 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 3.80 | 41,379 | 157,240 | 41,379 | ||
Apr 29 2016 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 3.80 | 41,379 | 157,240 | 41,379 | ||
Feb 16 2016 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Option Exercise | A | 2.86 | 7,407 | 21,184 | 7,407 | |
Feb 16 2016 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 2.86 | 8,395 | 24,010 | 8,395 | |
Feb 16 2016 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | A | 2.86 | 10,848 | 31,025 | 10,848 | |
Feb 16 2016 | ANTH | Anthera Pharmaceut ... | Olson Charles V | Chief Technology Of ... | Option Exercise | A | 2.86 | 5,626 | 16,090 | 5,626 | |
Feb 16 2016 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | Chief Executive Off ... | Option Exercise | A | 2.86 | 15,816 | 45,234 | 15,816 | |
Dec 24 2015 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | M | 2.89 | 10,000 | 28,900 | 2,500 | ||
Dec 24 2015 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Buy | M | 2.89 | 10,000 | 28,900 | 10,000 | 0 to 10 K | |
Nov 18 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | M | 1.61 | 12,500 | 20,125 | 107,500 | |
Nov 18 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Sell | S | 5.31 | 12,500 | 66,341 | 19,147 | 31.6 K to 19.1 K (-39.50 %) |
Nov 18 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Buy | M | 1.61 | 12,500 | 20,125 | 31,647 | 19.1 K to 31.6 K (+65.28 %) |
Nov 12 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Sell | S | 5.38 | 5,000 | 26,900 | 19,147 | 24.1 K to 19.1 K (-20.71 %) |
Oct 13 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Sell | S | 6.15 | 1,205 | 7,411 | 7,896 | 9.1 K to 7.9 K (-13.24 %) |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 9.48 | 30,000 | 284,400 | 30,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 9.48 | 50,000 | 474,000 | 50,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 9.48 | 180,000 | 1,706,400 | 180,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 9.48 | 170,000 | 1,611,600 | 170,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | A | 9.48 | 30,000 | 284,400 | 30,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | A | 9.48 | 60,000 | 568,800 | 60,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Option Exercise | A | 9.48 | 30,000 | 284,400 | 30,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Option Exercise | A | 9.48 | 40,000 | 379,200 | 40,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 9.48 | 30,000 | 284,400 | 30,000 | |
Sep 18 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 9.48 | 60,000 | 568,800 | 60,000 | |
May 22 2015 | ANTH | Anthera Pharmaceut ... | ENGLE STEVEN B | Option Exercise | A | 4.75 | 28,846 | 137,019 | 28,846 | ||
May 22 2015 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 4.75 | 28,846 | 137,019 | 28,846 | ||
May 22 2015 | ANTH | Anthera Pharmaceut ... | ZWEIFACH SANFORD S | Option Exercise | A | 4.75 | 28,846 | 137,019 | 28,846 | ||
May 22 2015 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 4.75 | 43,269 | 205,528 | 43,269 | ||
May 22 2015 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 4.75 | 28,846 | 137,019 | 28,846 | ||
May 22 2015 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 4.75 | 28,846 | 137,019 | 28,846 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 1.61 | 15,000 | 24,150 | 12,500 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ZWEIFACH SANFORD S | Option Exercise | A | 1.61 | 12,500 | 20,125 | 12,500 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 1.61 | 12,500 | 20,125 | 12,500 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 1.61 | 120,000 | 193,200 | 120,000 | |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 1,364 | 0 | 13,855 | 12.5 K to 13.9 K (+10.92 %) |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 1,364 | 0 | 9,101 | 10.5 K to 9.1 K (-13.03 %) |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | ENGLE STEVEN B | Option Exercise | A | 1.61 | 12,500 | 20,125 | 12,500 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | A | 1.61 | 120,000 | 193,200 | 120,000 | |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 1.61 | 16,250 | 26,163 | 16,250 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 1.61 | 12,500 | 20,125 | 12,500 | ||
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 1.61 | 330,000 | 531,300 | 330,000 | |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 12,500 | 0 | 89,337 | 76.8 K to 89.3 K (+16.27 %) |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 12,500 | 0 | 0 | 12.5 K to 0 (-100.00 %) |
Jan 02 2015 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Option Exercise | A | 1.61 | 120,000 | 193,200 | 120,000 | |
Aug 04 2014 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 2.89 | 12,500 | 36,125 | 12,500 | ||
Aug 04 2014 | ANTH | Anthera Pharmaceut ... | Mueller Brian | Option Exercise | A | 2.89 | 18,750 | 54,188 | 18,750 | ||
Jul 01 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Sell | J | 0.00 | 14,709 | 0 | 14,709 | 29.4 K to 14.7 K (-50.00 %) |
Jul 01 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 16,500 | 0 | 62,128 | 78.6 K to 62.1 K (-20.98 %) |
Jul 01 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Payment of Exercise | F | 3.39 | 699 | 2,370 | 14,709 | 15.4 K to 14.7 K (-4.54 %) |
Jul 01 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Buy | M | 2.08 | 2,000 | 4,160 | 13,845 | 11.8 K to 13.8 K (+16.88 %) |
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | SPIEGELMAN DANIEL K | Option Exercise | A | 3.35 | 12,500 | 41,875 | 12,500 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | ENGLE STEVEN B | Option Exercise | A | 3.35 | 12,500 | 41,875 | 12,500 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | ENGLE STEVEN B | Option Exercise | A | 3.35 | 18,750 | 62,813 | 18,750 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 3.35 | 15,625 | 52,344 | 15,625 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 3.35 | 12,500 | 41,875 | 12,500 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 3.35 | 12,500 | 41,875 | 31,250 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | Sager Philip | Option Exercise | A | 3.35 | 18,750 | 62,813 | 18,750 | ||
Jun 16 2014 | ANTH | Anthera Pharmaceut ... | ZWEIFACH SANFORD S | Option Exercise | A | 3.35 | 12,500 | 41,875 | 12,500 | ||
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | A | 3.30 | 12,871 | 42,474 | 12,871 | |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Grant | A | 0.00 | 3,864 | 0 | 24,147 | 20.3 K to 24.1 K (+19.05 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 3,323 | 0 | 20,283 | 23.6 K to 20.3 K (-14.08 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Option Exercise | A | 3.30 | 6,745 | 22,259 | 6,745 | |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Grant | A | 0.00 | 3,625 | 0 | 7,302 | 10.9 K to 7.3 K (-33.17 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Payment of Exercise | F | 3.30 | 529 | 1,746 | 3,677 | 4.2 K to 3.7 K (-12.58 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 3.30 | 10,070 | 33,231 | 10,070 | |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Grant | A | 0.00 | 3,864 | 0 | 10,465 | 14.3 K to 10.5 K (-26.97 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Payment of Exercise | F | 3.30 | 2,783 | 9,184 | 6,601 | 9.4 K to 6.6 K (-29.66 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 3.30 | 18,440 | 60,852 | 18,440 | |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Grant | A | 3.30 | 6,250 | 20,625 | 597,787 | 591.5 K to 597.8 K (+1.06 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Grant | A | 0.00 | 3,864 | 0 | 13,197 | 9.3 K to 13.2 K (+41.40 %) |
Mar 27 2014 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Payment of Exercise | F | 3.30 | 7,622 | 25,153 | 9,333 | 17 K to 9.3 K (-44.95 %) |
Dec 18 2013 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Option Exercise | A | 3.02 | 80,000 | 241,600 | 170,494 | |
Jul 02 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Payment of Exercise | F | 0.49 | 2,248 | 1,102 | 75,074 | 77.3 K to 75.1 K (-2.91 %) |
Jul 02 2013 | ANTH | Anthera Pharmaceut ... | LIU MAY | Chief Accounting Of ... | Payment of Exercise | F | 0.49 | 675 | 331 | 33,655 | 34.3 K to 33.7 K (-1.97 %) |
Jun 26 2013 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Buy | P | 0.53 | 100,000 | 53,000 | 128,201 | 28.2 K to 128.2 K (+354.60 %) | |
Jun 04 2013 | ANTH | Anthera Pharmaceut ... | DZIURZYNSKI BOGDAN | Buy | P | 0.59 | 10,000 | 5,900 | 10,000 | 0 to 10 K | |
May 21 2013 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Option Exercise | A | 0.61 | 5,400,000 | 3,294,000 | 5,400,000 | |
May 21 2013 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Gift | G | 0.00 | 100,000 | 0 | 591,537 | 691.5 K to 591.5 K (-14.46 %) |
May 21 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Option Exercise | A | 0.61 | 1,400,000 | 854,000 | 1,400,000 | |
May 21 2013 | ANTH | Anthera Pharmaceut ... | LOWE CHRISTOPHER P. | CFO and Chief Busin ... | Option Exercise | A | 0.61 | 1,300,000 | 793,000 | 1,300,000 | |
May 21 2013 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Option Exercise | A | 0.61 | 1,300,000 | 793,000 | 1,300,000 | |
May 20 2013 | ANTH | Anthera Pharmaceut ... | HENNEY CHRISTOPHER S | Option Exercise | A | 0.61 | 125,000 | 76,250 | 125,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | HEALY JAMES | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | SPIEGELMAN DANIEL K | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | ZWEIFACH SANFORD S | Option Exercise | A | 0.61 | 150,000 | 91,500 | 150,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | ZWEIFACH SANFORD S | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | DZIURZYNSKI BOGDAN | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | ||
May 20 2013 | ANTH | Anthera Pharmaceut ... | Thompson David E. | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | ||
Mar 27 2013 | ANTH | Anthera Pharmaceut ... | TRUEX PAUL F | President and CEO | Grant | A | 0.00 | 135,644 | 0 | 135,644 | 0 to 135.6 K |
Mar 27 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Grant | A | 0.00 | 49,519 | 0 | 77,322 | 27.8 K to 77.3 K (+178.11 %) |
Mar 27 2013 | ANTH | Anthera Pharmaceut ... | LOWE CHRISTOPHER P. | CFO and Chief Busin ... | Grant | A | 0.00 | 67,579 | 0 | 108,915 | 41.3 K to 108.9 K (+163.49 %) |
Mar 27 2013 | ANTH | Anthera Pharmaceut ... | Hislop Colin | Chief Medical Offic ... | Grant | A | 0.00 | 59,132 | 0 | 144,091 | 85 K to 144.1 K (+69.60 %) |
Feb 01 2013 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.66 | 5,700,000 | 3,762,000 | 7,462,000 | 1.8 M to 7.5 M (+323.50 %) |
Jan 29 2013 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.65 | 1,762,000 | 1,142,481 | 1,762,000 | 0 to 1.8 M |
Jan 11 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 4,009 | 0 | 99,937 | 95.9 K to 99.9 K (+4.18 %) |
Jan 11 2013 | ANTH | Anthera Pharmaceut ... | ODINK DEBRA | Chief Technology Of ... | Gift | G | 0.00 | 4,009 | 0 | 27,803 | 31.8 K to 27.8 K (-12.60 %) |